SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has ...
Partnership combines life sciences technology and clinical operations expertise to identify risk earlier, act during ...
A Research Triangle-based biologics and CDMO leader rejoins FUJIFILM to help clients turn biologic therapies into development ...
Aclaris Therapeutics, a Wayne, Pennsylvania-based clinical-stage biopharmaceutical company developing treatments for ...
Small cell lung cancer remains one of the most challenging forms of the disease to treat, but a new research initiative is ...
Vanda Pharmaceuticals, a Washington, D.C.-based biopharmaceutical company developing treatments for medical conditions with ...
CRB, a Kansas City, Missouri-based engineering, architecture, construction, and consulting firm serving the life sciences ...
Benefits of CyPath® Lung to be shared with North Carolina patient advocacy and healthcare community at November 5 “Battle of ...
Clinical validation study with PrismTcell use achieved approximately 2-fold higher ACR50 response rate to abatacept.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results